The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Sacroiliitis Treatment Market Between 2026 And 2030?
The sacroiliitis treatment market has experienced robust growth in recent years. It is anticipated to increase from $1.77 billion in 2025 to $1.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. The expansion observed historically can be attributed to the rising prevalence of inflammatory spinal disorders, the broader adoption of diagnostic imaging, enhanced comprehension of sacroiliac joint pathology, the proliferation of pain management clinics, and the accessibility of advanced pharmacological therapies.
The sacroiliitis treatment market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $2.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth over the forecast period include the increased acceptance of biologic drugs, a heightened demand for less invasive pain management therapies, the proliferation of outpatient orthopedic interventions, the expanding incorporation of digital diagnostic tools, and a greater emphasis on restoring long-term mobility. Key trends expected during this period involve the rising application of image-guided diagnostic methods, the increasing implementation of minimally invasive SI joint fusion procedures, a developing preference for biologic and targeted therapeutic options, the broadening scope of radiofrequency-based pain relief, and a stronger commitment to individualized treatment strategies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24688&type=smp
What Key Drivers Are Influencing The Growth Of The Sacroiliitis Treatment Market?
Future expansion of the sacroiliitis treatment market is anticipated due to a rise in joint disorder occurrences. Joint disorders are medical conditions impacting joints, leading to discomfort, swelling, rigidity, and restricted mobility, often stemming from injury, the aging process, autoimmune conditions, or infections. The rising frequency of these disorders is predominantly linked to the natural deterioration of joints in an aging population, which contributes to a greater occurrence of ailments such as osteoarthritis and other degenerative joint diseases. Sacroiliitis treatment offers benefits for joint disorders by mitigating inflammation and pain in the sacroiliac joints, thereby enhancing movement and general joint functionality, which can ease symptoms and avert additional joint damage. As an illustration, data from February 2024 by Arthritis Australia, an Australian non-profit, indicates that osteoarthritis (OA) is predicted to impact 2.35 million Australians by 2025, representing 57% of the total arthritis demographic and establishing it as Australia’s prevalent form of arthritis. The number of Australians living with OA is forecasted to grow to 3.11 million by 2040, marking a 32% increase compared to 2025 figures. This translates to an additional 762,515 individuals in Australia experiencing OA by 2040 relative to 2025. Consequently, the growing prevalence of joint disorders is a key factor propelling the expansion of the sacroiliitis treatment market.
Which Market Segments Are Examined In The Sacroiliitis Treatment Market Study?
The sacroiliitis treatment market covered in this report is segmented –
1) By Type: Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation, Electrical Stimulation
2) By Diagnosis: Imaging Tests, Physical Examination, Laboratory Tests, Other Diagnosis
3) By Route Of Administration: Oral, Injectable, Topical
4) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings
Subsegments:
1) By Medications: NSAIDs (Nonsteroidal Anti-Inflammatory Drugs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Agents, Analgesics
2) By Joint Injections: Corticosteroid Injections, Platelet-Rich Plasma (PRP) Injections, Hyaluronic Acid Injections, Prolotherapy
3) By Joint Fusion: Minimally Invasive SI Joint Fusion, Open SI Joint Fusion, Robotic-Assisted Fusion Techniques, Posterior Approach Fusion, Lateral Approach Fusion
4) By Radiofrequency Denervation: Conventional Radiofrequency Ablation, Cooled Radiofrequency Ablation, Pulsed Radiofrequency Ablation
5) By Electrical Stimulation: Transcutaneous Electrical Nerve Stimulation (TENS), Spinal Cord Stimulation (SCS), Peripheral Nerve Stimulation (PNS)
Which Upcoming Trends Are Expected To Influence The Sacroiliitis Treatment Market?
Major companies involved in the sacroiliitis treatment market are prioritizing the acquisition of regulatory approvals to expedite the introduction of new treatments, secure entry into the market, and enhance their competitive standing. These approvals represent the official permission granted by governmental health bodies, verifying that a medical treatment is both safe and effective for the public. As an illustration, in December 2023, Spinal Simplicity, a US-based manufacturer of medical equipment, secured FDA 510(k) clearance for its Liberty-SI Lateral Implant System, which is a minimally invasive, transfixing device engineered for sacroiliac joint fusion in individuals suffering from conditions like sacroiliac disruptions and degenerative sacroiliitis. This system employs a lateral technique, involving the insertion of one or two titanium implants through the ilium and extending across the SI joint into the sacrum, thereby facilitating stabilization and fusion. The implants themselves incorporate a central threaded body, deployable wings, and compressive elements; they come in various sizes and are coated with hydroxyapatite to promote better integration. This procedure aims to be safer and less intrusive, potentially leading to shorter anesthesia durations and improved results for patients.
Who Are The Primary Competitors In The Sacroiliitis Treatment Market?
Major companies operating in the sacroiliitis treatment market are Pfizer Inc, Johnson And Johnson, AbbVie Inc, Novartis AG, Eli Lilly And Company, Boehringer Ingelheim International GmbH, Amgen Inc, Biogen Inc, Sandoz Group AG, UCB SA, Hikma Pharmaceuticals PLC, Samsung Bioepis Co Ltd, Lupin Limited, Zydus Lifesciences Limited, Celltrion Healthcare Co Ltd, Torrent Pharmaceuticals Limited, Globus Medical, Orthofix Medical Inc, Coherus BioSciences Inc, SI BONE Inc, Medtronic plc
Read the full sacroiliitis treatment market report here:
https://www.thebusinessresearchcompany.com/report/sacroiliitis-treatment-global-market-report
Which Region Is Expected To Register The Fastest Growth In The Sacroiliitis Treatment Market?
North America was the largest region in the sacroiliitis treatment market in2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacroiliitis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sacroiliitis Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24688&type=smp
Browse Through More Reports Similar to the Global Sacroiliitis Treatment Market 2026, By The Business Research Company
Diverticulitis Disease Global Market Report
https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report
Neutropenia Biologic Drug Treatments Global Market Report
Psoriatic Arthritis Treatments Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model